Communities

A key reason for joining TOPRA is to network with other regulatory professionals from all over the world. We provide opportunities to exchange news, views and ideas face-to-face and online, formally and informally. Our ever-expanding collection of communities groups is segmented by region and topic.


* * Now online * *

Our new and improved Communities platform is now available for use.

Take me there

 

'TOPRA In' regional groups

'TOPRA In' groups support regulatory professionals living and working in a country or region, providing a forum for discussion and networking.

The groups aim to:

  • Develop a local TOPRA networking arm in individual countries for meetings and discussion
  • Support the TOPRA members living and working in a country and increase the membership of regulatory professionals
  • Work cooperatively with other not-for-profit or government organisations and relevant academic institutions. 

TOPRA In groups worldwide
Current groups

  • Austria
  • Benelux
  • Central & Eastern Europe
  • England & Wales
  • France
  • Germany
  • India
  • Ireland
  • Italy
  • North America
  • Scotland
  • Spain
  • Sweden
  • Switzerland

Get involved

More 'TOPRA In' groups are currently being developed. To find out more or to get involved with setting up a group, email our membership team.

Upcoming TOPRA In community events

Start dateTitleDescriptionCityCountry
14/02/2023TOPRA in Sweden: Medical Devices-Combination ProductsThis evening is an excellent opportunity to discuss experiences with the new regulations MDR and IVDR which were fully implemented from 26 May 2021 and 26 May 2022 respectively. How have they affected the work at the Medical Products Agency and the companies? How have they affected clinical trials? What applies to combination products, when a medicine contains a medical device component (Article 117)? And what does consultation mean for a medical device with medicinal substance? Open to anyone working with and interested in regulatory issues for pharmaceuticals and medical devices.UppsalaSwedenSWEFEB23

 

Special Interest Networks (SPINs)

TOPRA's Special Interest Networks:

  • Promote contact between regulatory professionals working in the same specialist sector
  • Provide a forum for exchanging views and ideas and for mutual support
  • Ensure that the needs of these sectors are taken into account in the TOPRA training programme and to encourage expert input into the content of courses
  • Encourage contributions to Regulatory Rapporteur on specialist topics.

Current SPINs:

 SPIN Networks graphic

New Global SPIN

The Global SPIN was set up in December 2021 based on member requests to create a dedicated forum for those who have ‘Rest of the World/ROW’ or ‘Global’ responsibilities within their roles. This space allows members from across the world to ask questions, share information, and generally to discuss topics linked to global markets outside the remit of EU/US regulations.

Upcoming Special Interest Network (SPIN) events

Start dateTitleDescription
14/02/2023MedTech SPIN Webinar: EU-MDR New Rule 21In this webinar, Theresa Jeary will shed some light on rule 21, its intent and how manufacturers can develop an effective regulatory strategy to successfully navigate conformity assessments and ensure Annex I to Directive 2001/83/EC requirements are met.MEDTJAN23
08/03/2023TOPRA Fellows Presentation and DinnerTOPRA is delighted to invite Fellows and Honorary Fellows to a presentation by Dr June Raine DBE, CEO of MHRA (the Medicines and Healthcare Products Regulatory Agency), followed by a three course dinner at a nearby hotel.FELMAR23
08/03/2023TOPRA Fellows Presentation and DinnerTOPRA is delighted to invite Fellows and Honorary Fellows to a presentation by Dr June Raine DBE, CEO of MHRA (the Medicines and Healthcare Products Regulatory Agency), followed by a three course dinner at a nearby hotel.FELMAR23.2
08/03/2023TOPRA Fellows Presentation - OnlineTOPRA is delighted to invite Fellows and Honorary Fellows to a presentation by Dr June Raine DBE, CEO of MHRA (the Medicines and Healthcare Products Regulatory Agency).FELMAR23OL